Detalhe da pesquisa
1.
Pulmonary non-tuberculous mycobacterial infections: current state and future management.
Eur J Clin Microbiol Infect Dis
; 39(5): 799-826, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31853742
2.
Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.
Antimicrob Agents Chemother
; 63(10)2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31405862
3.
Fluoroquinolone Efficacy against Tuberculosis Is Driven by Penetration into Lesions and Activity against Resident Bacterial Populations.
Antimicrob Agents Chemother
; 63(5)2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30803965
4.
Synthesis and Testing of Analogs of the Tuberculosis Drug Candidate SQ109 against Bacteria and Protozoa: Identification of Lead Compounds against Mycobacterium abscessus and Malaria Parasites.
ACS Infect Dis
; 9(2): 342-364, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706233
5.
Investigation of ( S)-(-)-Acidomycin: A Selective Antimycobacterial Natural Product That Inhibits Biotin Synthase.
ACS Infect Dis
; 5(4): 598-617, 2019 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30652474
6.
Impact of immunopathology on the antituberculous activity of pyrazinamide.
J Exp Med
; 215(8): 1975-1986, 2018 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30018074